23 November 2020
S-VENTURES PLC
("S-Ventures" or the "Company")
Provision of further Loan into Coldpress Foods Ltd
S-Ventures PLC is pleased to announce, further to the announcement of 22 September 2020, that the Company has agreed to invest a further £75,000 into Coldpress Foods Ltd, via a secured convertible loan note ("CLN").
About Coldpress Foods:
Coldpress Foods provides all-natural support to non-stop, frenetic lifestyles by providing Europe's first Range of Vitamin Fortified, Super Juices & Smoothies www.cold-press.com
Terms:
A seventeen-month CLN has been put in place at an annual interest rate of 15%, with the first interest payment due in seven months of the CLN being provided. The loan is convertible into shares of Coldpress Foods in the event of default. In the event that the CLN is converted at seven months of its term commencement, the Company will be issued with a further 4.5% of the enlarged equity of Coldpress Foods.
S-Ventures currently has an equity position of 3.3% in Coldpress Foods, with an option to increase its stake to 6.2%. Today's announcement allows the Company, in the event of default, to potentially own up to 10.7%, including the option announced on 22 September 2020, assuming the option is exercised and the Company loan is converted into equity of Coldpress Foods.
Scott Livingston, Executive Director of S-Ventures comments:
"I am delighted to report that we are further supporting Coldpress Foods and assisting them to grow their brand faster. Please see their website for further information www.cold-press.com."
The directors of the issuer accept responsibility for the contents of this announcement.
For further information, please contact:
| The Company Robert Hewitt +44 (0) 1932 400 224 |
|
|
| |
||
| AQSE Corporate Adviser: Peterhouse Capital Limited |
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.